Lupin launches Ethacrynic Acid Tablets USP, 25 mg Medical Dialogues Bureau26 Feb 2020 3:27 PM ISTThe product would be manufactured at Lupin's Nagpur OSD facility, India.
USFDA completes inspection of Lupin's Aurangabad facility Medical Dialogues Bureau17 Feb 2020 4:18 PM ISTMumbai: Pharma major Lupin Limited (Lupin) announced the completion of the United States Food and Drug Administration (U.S. FDA) inspection carried...
Lupin Pithampur unit gets 2 USFDA observations Medical Dialogues Bureau13 Feb 2020 12:52 PM ISTThe inspection of the company's Pithampur Unit-I facility by the United States Food and Drug Administration (USFDA) has been completed, Lupin said in...
Lupin posts net loss at Rs 835 crore in Q3 Medical Dialogues Bureau8 Feb 2020 10:15 AM ISTNew Delhi: Pharma firm Lupin on Thursday reported widening of its consolidated net loss to Rs 835 crore for the quarter ended December 2019 on account...
Lupin gets USFDA nod for generic version of Arava Tablets Medical Dialogues Bureau6 Feb 2020 1:08 PM IST Leflunomide Tablets USP is a generic equivalent of Arava Tablets, 10 mg and 20 mg, of Sanofi- Aventis, Lupin said.Mumbai: Pharma major Lupin Limited...
Lupin Pithampur facilities complete successful MHRA inspection MD bureau28 Jan 2020 2:06 PM ISTNew Delhi: Pharma major Lupin on Monday said the UK Medicines and Healthcare products Regulatory Agency (MHRA), the regulatory agency of the United...
Lupin Foundation Wins IDMA Corporate Citizen Award 2019 Medical Dialogues Bureau23 Jan 2020 9:45 AM ISTMumbai: Pharma major Lupin Limited (Lupin) recently announced that its corporate social responsibility (CSR) arm, Lupin Foundation, has won the...
Lupin concludes third edition of medical symposiums for Indian urology community Medical Dialogues Bureau22 Jan 2020 12:50 PM ISTMumbai: Pharma major Lupin Limited (Lupin) recently announced that it has successfully concluded the third edition of its series of medical symposiums...
Lupin gets 5 USFDA observations for Vizag facility Medical Dialogues Bureau20 Jan 2020 11:24 AM IST The inspection for the API facility at Vizag closed with five 483 observations, Lupin said. New Delhi: Drug firm Lupin on Saturday said it has...
Lupin gets 2 observations from USFDA for Nagpur facility Medical Dialogues Bureau13 Jan 2020 11:58 AM ISTDrug firm Lupin on Saturday said it has received two observations from the US health regulator following the inspection of its Nagpur manufacturing...
NPPA fixes retail price of 44 combo drugs including Metformin, Vildagliptin, Paracetamol; Details Farhat Nasim20 Dec 2019 11:55 AM ISTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
CDSCO declares 36 samples of Atorvastatin, Metformin, Paracetamol, others as Not of Standard Quality Farhat Nasim25 Nov 2019 3:41 PM ISTNew Delhi: The nodal drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared batches of 36 drugs as not of standard...
